ARTICLES
By: 17 March 2014
Pelvic organ prolapse: current understanding, assessment and management

Kosturika Ash and Alok Ash review the current literature regarding prolapse, including assessment techniques and means of treatment.

 

Introduction

Genito-urinary prolapse or pelvic organ prolapse (POP) is a common gynaecological problem, the presentation of which varies in type and severity among patients.

 

Epidemiology of POP

It is difficult to know the exact prevalence of pelvic organ prolapse since many patients do not report it and symptom-based diagnosis underestimates the true prevalence of the condition.

In developed countries, the prevalence is high among postmenopausal women,1-3 whereas in developing countries, the condition is also common in women of reproductive age.4,5 The global prevalence of POP is reported to be 2-20 percent in women under the age of 45 years…6

 

For the full article, contact us and ask about subscription:

David Warne
T: 01423 851 150
E: david.warne@barkerbrooks.co.uk

 

References

  1. Fritel X, Varnoux N, Zins M, Breart G, Ringa V: Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol 2009, 113(3): 609–616.
  2. Barber MD, Neubauer NL, Klein-Olarte V: Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? Am J Obstet Gynecol 2006, 195(4): 942-948
  3. Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL: Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007, 109(6):1396–1403.
  4. Bonetti TR, Erpelding A, Pathak LR: Listening to “felt needs”: investigating genital prolapse in western Nepal. Reprod Health Matters 2004, 12(23):166–175.[Cross Ref. BMC Women’s Health 2013, 13:22]
  5. Lukman Y: Utero-vaginal prolapse: a rural disability of the young. East Afr Med J 1995, 72(1):2–9. [Cross Ref. BMC Women’s Health 2013, 13:22]
  6. WHO: Report on the Regional Reproductive Strategy Workshop: South East Asia Region. Geneva, Switzerland: World Health Organization; 1995.
  7. King’s College Hospital. Pelvic Organ Prolapse: Information for outpatients. www.kch.nhs.uk. PL541.1 May 2012 [accessed 28 Dec 2012]
  8. Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999; 180(2 Pt 1): 299-305.
  9. RCOG. Information for you: Pelvic organ prolapse, March 2013
  10. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL: Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997, 89(4): 501-506.
  11. Fialkow MF, Newton KM, Lentz GM, Weiss NS: Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19(3):437-440.
  12. Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS: Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001; 98(4): 646.
  13. Graham CA, Mallett VT. Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2001;185(1):116–120. [PubMed: 11483914]
  14. Thom DH, van den Eeden SK, Ragins AI, et al. Differences in prevalence of urinary incontinence by race/ethnicity. J Urol 2006;175(1):259–264. [PubMed: 16406923]
  15. Dooley Y, Kenton K, Cao G, et al. Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol 2008;179(2):656–661. [PubMed: 18082211]
  16. Shah AD, Kohli N, Rajan SS, Hoyte L. Racial characteristics of women undergoing surgery for pelvic organ prolapse in the United States. Am J Obstet Gynecol 2007;197(1):70.e1–70.e8. [PubMed: 17618763]
  17. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US. JAMA. 2008 September 17; 300(11): 1311–1316. doi:10.1001/jama.300.11.1311
  18. MacLennan, A. H., Taylor, A. W., Wilson, D. H. and Wilson, D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. BJOG: An International Journal of Obstetrics & Gynaecology, 2000; 107:1460–1470.
  19. Lukacz ES, Lawrence JM, Contreras R, Nager CW, Luber KM. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol 2006;107(6):1253-1260.
  20. Delancey JO, Kearney R, Chou Q, et al. The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol. 2003; 101:46–53.
  21. Dietz HP, Lanzarone V. Levator trauma after vaginal delivery. Obstet Gynecol. 2005; 106:707–712.
  22. Chan SS, Cheung RY, Yiu AK, et al. Prevalence of levator ani muscle injury in Chinese women after first delivery. Ultrasound Obstet Gynecol. 2012; 39:704–709. [PubMed: 22045587]
  23. Albrich SB, Laterza RM, Skala C. Impact of mode of delivery on levator morphology: a prospective observational study with three-dimensional ultrasound early in the postpartum period. BJOG. 2012; 119: 51–60.
  24. Shek KL and Dietz HP. Intrapartum risk factors for levator trauma. BJOG. 2010; 117:1485–1492.
  25. Hösli I. Influence of pregnancy and delivery to the pelvic floor. Ther Umsch 2010; Jan;67(1):11-8. doi: 10.1024/0040-5930/a000003. [PubMed – indexed for MEDLINE].
  26. de Tayrac R, Panel L, Masson G, Mares P. [Episiotomy and prevention of perineal and pelvic floor injuries]. J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S24-1S31 [PubMed: Indexed for MEDLINE]
  27. Memon H and Handa VL. Pelvic floor disorders following vaginal or cesarean delivery. Curr Opin Obstet Gynecol. 2012 October; 24(5): 349–354. doi:10.1097/GCO.0b013e328357628b
  28. Lammers, K., Lince, S. L., Spath, M. A., van Kempen, L. C., Hendriks, J. C., Vierhout, M. E., & Kluivers, K. B. Pelvic organ prolapse and collagen-associated disorders. Inter